Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Boston Scientific reportedly agreed to settle a lawsuit brought by a woman who alleged she was injured by 1 of the company’s transvaginal mesh devices, which have been the target of more than 26,000 product liability lawsuits.
The confidential settlement was reached yesterday, a week after a trial began in U.S. District Court for the Central District of California, according to plaintiff’s attorney Jim Perdue of Perdue & Kidd, Reuters reported. Read more
Nevro Corp. vowed to “vigorously defend” 1 of its patents against a pair of challenges from Boston Scientific.
Nevro’s Senza device, which won pre-market approval from the FDA last week, is designed to deliver up to 10,000Hz to the spinal cord, allowing it to avoid the tingling sensation known as paresthesia that bothers some patients. Read more
Biotronik said its entry into a hot replacement heart valve market passed the safety endpoint of a 1st-in-human trial.
The German medical device giant said the Biovalve trial of its transcatheter aortic valve implant established the device’s early safety at 30 days. Read more